We have a number of papers to note, particularly a paper from Betsi Cadwaladr University Health Board. Following our evidence session on 9 March with Betsi Cadwaladr University Health Board, I wrote to them, as agreed by yourselves, seeking clarification on a number of issues. Members present will recall that some of the questions related to mental health services, vascular services, financial management and service transformation. I believe that there were also questions relating to human resources matters and whether persons still in positions of management were those criticised in the report and whether that's tenable.
The letter we received from the health board notes that the health board have approved their integrated medium-term plan, or IMTP, for the next three years, with detailed information about their plans for 2022/23. The Welsh Government's response to this plan is not yet available, and in previous years did not approve the three-year plan for the health board, only one-year plans. Well, the health board plan's early priorities are planned care, with a transformation focus on specialities, including orthopaedics, urology and ophthalmology. Their other main priority is unscheduled care, with an immediate focus on improving discharge pathways to reduce delays.
Their letter to us notes that the targeted intervention framework is, quote,
'by design, a self-assessment process.'
It also notes that the health board has
'engaged external support to give an impartial view'
of their evidence gathering and progress assessment, but they provided us with no further details.
Their IMTP's stated priorities don't include mental health services, although, of course, we raised those, but they do include some general information about the work under way in this area. Whilst their letter refers to appendix 2 of the IMTP as providing additional information on the expected improvements in this area, this appendix refers to planned care and does not appear to include the information referred to. The plan doesn't mention accident and emergency services, and it's notable that performance against the four-hour target at Ysbyty Maelor Wrecsam and Ysbyty Glan Clwyd have consistently been close to or below 50 per cent. I think, as Members are well aware, Healthcare Inspectorate Wales declared the emergency department in Ysbyty Glan Clwyd as a service requiring significant improvement this month.
In relation to vascular services, the letter refers to the process for improvement, which includes plans and correspondence from the Minister for Health and Social Services. It's notable that the board was set a three-month timescale for improvement in February, and the update for May 2022, this month, has not yet been published.
In relation to transformation and finances, the letter and IMTP notes that BC health board must make £105 million in savings over the next three years. The health board must make significant transformational changes to ensure that services can continue to be delivered when the Welsh Government's additional financial support ceases. The health board's letter and plan do not detail how theses savings will be achieved, although a broad set of, quote, 'opportunities to make savings' are listed in areas such as planned care, unscheduled care, mental health and 'other'.
There is some information in the letter on regional treatment centres, and whilst the letter notes that they will incorporate a range of services, there is no indication of whether these are new services, or whether these involve service relocations that require consultation. They state that this process will be completed by July 2025.
So, the committee will no doubt wish to revisit these issues with the health board later this year when, as agreed, we will hope to have them back before us. Do Members wish to raise any comments before we move on? You will recall that the letter we sent after the evidence session we held, and the discussion we then had about that and the concerns we raised, was very much focused on audit matters, specifics—when, where, why, where and how—and this is the response received. So, are Members content for me to note this at this point? Do you wish to comment further? Or do you feel that we should write back to the health board for more specific information ahead of our intended evidence session with them in autumn? Mabon.